Skip to main content

Advertisement

SpringerLink
Log in

Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Considering the epidemiologic impact of benign prostatic hyperplasia (BPH), the use of minimally invasive surgery in the treatment of this condition is one of the main ambitions of contemporary urology. Compared with the prevalence of BPH and LUTS in elderly men, only a small percentage of patients requires surgery for indications such as renal insufficiency, chronic retention, and infection. The majority of patients seek treatment because of the bothersome nature of their symptoms and expect improvement in their quality of life. The goal of interventional therapy is to restore the comfort and well being of the patients, including preserving their sexuality. Therefore, there is increased focus on the quality of life and sexual function in the evaluation of the out-come of interventional therapy for BPH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. O’Leary MP: LUTS, ED, QOL: alphabet soup or real concerns to aging men? Urology 2001, 56:7–11. During the last decade there was a change in the philosophy concerning the interpretation and relative value of outcome variables of BPH. This is an excellent update of the available evaluation tools concerning quality of life and sexuality related to lower urinary tract symptoms.

    Article  Google Scholar 

  2. Blaivas JG: The bladder is an unreliable witness. Neurourol Urodyn 1996, 15:443–445.

    Article  PubMed  CAS  Google Scholar 

  3. Donovan JL, Peters TJ, Abrams P, et al.: Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol 2000, 164:1948–1955.

    Article  PubMed  CAS  Google Scholar 

  4. Donovan JL, Kay HE, Peters TJ, et al.: Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-‘BPH’ Study. International Continence Society—Benign Prostatic Hyperplasia. Br J Urol 1997, 80:712–721.

    PubMed  CAS  Google Scholar 

  5. Hansen BJ, Mortensen S, Mensink HJ, et al.: Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group. Br J Urol 1998, 81:36–41.

    PubMed  CAS  Google Scholar 

  6. Barry MJ, Fowler FJ, O’Leary MP, et al.: Measuring disease-spe-cific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association. Med Care 1995, 33:AS145-AS155.

    Article  PubMed  CAS  Google Scholar 

  7. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC: Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function. Urology 2000, 56:477–481.

    Article  PubMed  CAS  Google Scholar 

  8. O’Leary MP, Fowler FJ, Lenderking WR, et al: A brief male sexual function inventory for urology. Urology 1995, 46:697–706.

    Article  PubMed  CAS  Google Scholar 

  9. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989, 141:243–247.

    PubMed  CAS  Google Scholar 

  10. Horninger W, Unterlechner H, Strasser H, Bartsch G: Transurethral prostatectomy: mortality and morbidity. Pros-tate 1996, 28:195–200.

    Article  CAS  Google Scholar 

  11. Uchida T, Ohori M, Soh S, et al.: Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999, 53:98–105.

    Article  PubMed  CAS  Google Scholar 

  12. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP: Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999, 162:1307–1310.

    Article  PubMed  CAS  Google Scholar 

  13. Chander J, Gupta U, Mehra R, Ramteke VK: Safety and efficacy of transurethral resection of the prostate under sedoanalgesia. BJU Int 2001, 86:220–222.

    Article  Google Scholar 

  14. Birch BR, Gelister JS, Parker CJ, Chave H, Miller RA: Transurethral resection of prostate under sedation and local anesthesia (sedoanalgesia). Experience in 100 patients. Urology 1991, 38:113–118.

    Article  PubMed  CAS  Google Scholar 

  15. Hanbury DC, Sethia KK: Erectile function following transurethral prostatectomy. Br J Urol 1995, 75:12–13.

    PubMed  CAS  Google Scholar 

  16. Tscholl R, Largo M, Poppinghaus E, Recker F, Subotic B: Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995, 153:1491–1493.

    Article  PubMed  CAS  Google Scholar 

  17. Soderdahl DW, Knight RW, Hansberry KL: Erectile dysfunction following transurethral resection of the prostate. J Urol 1996, 156:1354–1356.

    Article  PubMed  CAS  Google Scholar 

  18. Bieri S, Iselin CE, Rohner S: Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy. 1997, Scand J Urol Nephrol 31:545–548.

    Article  PubMed  CAS  Google Scholar 

  19. Yarnitsky D, Sprecher E, Vardi Y: Penile thermal sensation. J Urol 1996, 156:391–393.

    Article  PubMed  CAS  Google Scholar 

  20. Lefaucheur JP, Yiou R, Salomon L, Chopin DK, Abbou CC: Assessment of penile small nerve fiber damage after transurethral resection of the prostate by measurement of penile thermal sensation. J Urol 2000, 164:1416–1419. An original and promising approach to the neurophysiologic evaluation of surgery-induced erectile dysfunction. In the future, such objective investigations will be increasingly required due to the increasing demand of surgery minimizing sexual sequelae.

    Article  PubMed  CAS  Google Scholar 

  21. Ornstein DK, Rao GS, Smith DS, Andriole GL: The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 1997, 157:880–883; discussion 883–884.

    Article  PubMed  CAS  Google Scholar 

  22. Talic RF, Al Kudair WK, El Tiraifi AE, et al.: The ‘Wing’ versus the ‘Vapor Cut’ electrodes in transurethral electrovaporization-resection of the prostate: comparative changes in safety parameters. Urol Int 2000, 65:95–99.

    Article  PubMed  CAS  Google Scholar 

  23. Yajima M, Baba K, Yanagisawa N, et al.: Clinical study of transurethral surgery for benign prostatic hyperplasia using a thick loop (VaporTome). Hinyokika Kiyo 2000, 46:247–250.

    PubMed  CAS  Google Scholar 

  24. Kupeli S, Soygur T, Yilmaz E, Budak M: Combined transurethal resection and vaporization of the prostate using newly designed electrode: a promising treatment alternative for benign prostatic hyperplasia. J Endourol 1999, 13:225–228.

    PubMed  CAS  Google Scholar 

  25. Perlmutter AP, Vallancien G: Thick loop transurethral resection of the prostate. Eur Urol 1999, 35:161–165.

    Article  PubMed  CAS  Google Scholar 

  26. Ishikawa N, Goya N, Iguchi Y, et al.: Comparison of the depth of the desiccated zone with selected vaporizing-cutting electrodes: a basic study in animals. BJU Int 2000, 85:754–758.

    Article  PubMed  CAS  Google Scholar 

  27. Talic RF, Al Rikabi AC: Transurethral vaporization-resection of the prostate versus standard transurethral prostatectomy: comparative changes in histopathological features of the resected specimens. Eur Urol 2000, 37:301–305.

    Article  PubMed  CAS  Google Scholar 

  28. Talic RF: Transurethral electrovaporization-resection of the prostate using the “wing” cutting electrode: preliminary results of safety and efficacy in the treatment of men with prostatic outflow obstruction. Urology 1999, 53:106–110.

    Article  PubMed  CAS  Google Scholar 

  29. Talic RF, El Tiraifi A, El Faqih SR, et al.: Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology 2000, 55:886–890.

    Article  PubMed  CAS  Google Scholar 

  30. Moody JA, Lingeman JE: Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol 2001, 165:459–462.

    Article  PubMed  CAS  Google Scholar 

  31. Gilling PJ, Kennett KM, Fraundorfer MR: Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000, 14:757–760. This is a rigorous and informative study that provides essential information on the current status and future role of laser resection of the prostate.

    Article  PubMed  CAS  Google Scholar 

  32. Gilling PJ, Mackey M, Cresswell M, et al.: Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol 1999, 162:1640–1644.

    Article  PubMed  CAS  Google Scholar 

  33. Le Duc A, Gilling PJ: Holmium laser resection of the prostate. Eur Urol 1999, 35:155–160.

    Article  PubMed  Google Scholar 

  34. Matsuoka K, Iida S, Tomiyasu K, Shimada A, Noda S: Transurethral holmium laser resection of the prostate. J Urol 2000, 163:515–518.

    Article  PubMed  CAS  Google Scholar 

  35. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de la Rosette JJ: Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001, 165:1533–1538. A well-designed study allowing a better understanding of the relative merits of thermotherapy and traditional transurethral resection of the prostate.

    Article  PubMed  CAS  Google Scholar 

  36. Francisca EA, D’Ancona FC, Meuleman EJ, Debruyne FM, de la Rosette JJ: Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999, 161:486–490.

    Article  PubMed  CAS  Google Scholar 

  37. Arai Y, Aoki Y, Okubo K, et al.: Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000, 164:1206–1211.

    Article  PubMed  CAS  Google Scholar 

  38. D’Ancona FC, Francisca EA, Hendriks JC, Debruyne FM, de la Rosette JJ: The predictive value of baseline variables in the treatment of benign prostatic hyperplasia using high-energy transurethral microwave thermotherapy. Br J Urol 1998, 82:808–813.

    PubMed  CAS  Google Scholar 

  39. Bolmsjo M, Sturesson C, Wagrell L, Andersson-Engels S, Mattiasson A: Optimizing transurethral microwave thermotherapy: a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol 1998, 81: 811–816.

    PubMed  CAS  Google Scholar 

  40. Djavan B, Bursa B, Basharkhah A, et al.: Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy. Urology 2000, 55:51–57.

    Article  PubMed  CAS  Google Scholar 

  41. Muschter R, Schorsch I, Danielli L, et al.: Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol 2000, 164:1565–1569.

    Article  PubMed  CAS  Google Scholar 

  42. Arai Y, Okubo K, Okada T, Maekawa S, Aoki Y, Maeda H: Interstitial laser coagulation for management of benign prostatic hyperplasia: a Japanese experience. J Urol 1998, 159:1961–1965.

    Article  PubMed  CAS  Google Scholar 

  43. Kletscher BA, Oesterling JE: Transurethral incision of the prostate: a viable alternative to transurethral resection. Semin Urol 1992, 10: 265–272.

    PubMed  CAS  Google Scholar 

  44. Riehmann M, Knes JM, Heisey D, Madsen PO, Bruskewitz RC: Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology 1995, 45:768–775.

    Article  PubMed  CAS  Google Scholar 

  45. Graversen PH, Gasser TC, Larsen EH, Dorflinger T, Bruskewitz RC: Transurethral incisions of the prostate under local anaesthesia in high-risk patients: a pilot study. Scand J Urol Nephrol Suppl 1987, 104:87–90.

    PubMed  CAS  Google Scholar 

  46. Irani I, Bon D, Fournier F, Dore B, Aubert J: Patient acceptability of transurethral incision of the prostate under local anaesthesia. Br J Urol 1996, 78:904–906.

    PubMed  CAS  Google Scholar 

  47. Yang Q, Abrams P, Donovan J, Mulligan S, Williams G: Transurethral resection or incision of the prostate and other therapies: a survey of treatments for benign prostatic obstruction in the UK. BJU Int 1999, 84:640–645.

    Article  PubMed  CAS  Google Scholar 

  48. Jepsen JV, Bruskewitz RC: Recent developments in the surgical management of benign prostatic hyperplasia. Urology 1998 51: 23–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Urologie CHU Henri Mondor, 51 Av. du Ml. de Lattre de Tassigny, 94010, Créteil, France

    András Hoznek MD & Clément-Claude Abbou MD

Authors
  1. András Hoznek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clément-Claude Abbou MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoznek, A., Abbou, CC. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function. Curr Urol Rep 2, 311–317 (2001). https://doi.org/10.1007/s11934-001-0070-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-001-0070-4

Keywords

Search

Navigation